FDA Chief Expects J&J Pause to Run "A Matter of Days"
4/13/21 12:51 PM
Federal officials expect their recommended pause on Johnson & Johnson COVID-19 vaccines will last "a matter of days," the head of the U.S. Food and Drug Administration said Tuesday. Acting FDA Commissioner Dr. Janet Woodcock said the exact time frame will depend on what officials learn over the next few days in their review of six cases of a severe blood clot reported after receiving the J&J shot, which she said seems to be "extremely rare."
Get the rest of the story!
Click here to start your free, no‑obligation, 21-day trial.
Latest DPH COVID-19 Data
FREE for SHNS subscribers!